No Data
No Data
Regeneron Pharmaceuticals Q1 Adj. EPS $8.22 Misses $8.82 Estimate, Sales $3.03B Miss $3.29B Estimate
Earnings Scheduled For April 29, 2025
Here's the Major Earnings Before the Open Tomorrow
SA Analyst Downgrades: TSLA, AAPL, T, PG, HPE, GILD, LRCX, ARCC
Alnylam, Halozyme Among Latest Firms to Win EU Backing for Drugs
Insights Into Regeneron Pharmaceuticals's Upcoming Earnings